
SpringWorks Therapeutics Inc (SWTX)
US$ 44.72-0.57%
Price Chart
Key Statistics
Market Cap
$ 3.49B
P/E Ratio
0.00
Revenue (TTM)
$ 219.67M
Volume
7.71M
52W High
$ 62.00
52W Low
$ 28.21
Dividend Yield
0.00%
Beta
0.77
Technicals
50-Day MA
44.6068
200-Day MA
40.0442
52 Week High
62
52 Week Low
28.21
About SWTX
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare dise.
Employees
368
Headquarters
Stamford, CT
CEO
Mr. Saqib Islam J.D.
Latest News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
3 days ago • Google News
SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Misses Revenue Estimates - MSN
5 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg